Recombinant Human IGFBP6 Protein，His

IGFBP6 (Insulin-like Growth Factor Binding Protein 6) is a member of the IGFBP family that plays a critical role in regulating the biological effects of insulin-like growth factors (IGFs), which are essential for growth and development. The significance of IGFBP6 has gained attention due to its involvement in various physiological and pathological processes, including cell proliferation, apoptosis, and tumorigenesis. Research indicates that IGFBP6 can modulate IGF activity by either inhibiting or enhancing IGF signaling, which suggests its potential regulatory role in cancer biology, particularly in the context of different tumors. Furthermore, IGFBP6 is expressed in various tissues, indicating its multifunctional nature in development, metabolism, and disease states. The recombinant protein has been of particular interest for its potential therapeutic applications, as understanding the mechanisms of IGFBP6 can provide insights into targeted treatments for diseases where IGF signaling is dysregulated. Therefore, the recombinant production of IGFBP6 facilitates detailed studies into its structure-function relationships, interactions with IGFs, and its potential as a biomarker or therapeutic agent in conditions such as cancer and metabolic disorders. Researchers are increasingly focused on characterizing IGFBP6 at a molecular level, elucidating its pathways, and exploring how its modulation can lead to innovative treatment strategies, making it a promising target for future biomedical research.